Skip to main content
logo
Adial Pharmaceuticals, Inc. (ADIL)
NASDAQ: ADIL · Real-Time Price · USD
3.920
-0.300 (-7.11%)
Oct 23, 2026, 4:00 PM EDT - Market closed

Adial Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
10672657
Market Cap Growth
31.97%-10.34%188.66%-60.76%-89.79%131.15%
Enterprise Value
-18112050
Last Close Price
3.925.5025.2546.50134.381687.50

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
65.981.111.610.561.7616.12
P/TBV Ratio
-1.111.610.561.7720.21

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-----0.07
Net Debt / Equity Ratio
-184.05-1.11-0.92-0.69-1.22-1.65
Net Debt / EBITDA Ratio
2.500.750.450.410.370.33
Net Debt / FCF Ratio
2.580.910.540.420.360.48
Quick Ratio
5.614.213.844.332.242.23
Current Ratio
5.634.434.164.902.672.37
Return on Equity (ROE)
-2011.64%-170.73%-323.80%-190.27%-318.27%-518.38%
Return on Assets (ROA)
-40.02%-83.20%-105.88%-82.24%-102.77%-170.58%
Return on Capital Employed (ROCE)
-47.90%-147.80%-203.60%-168.70%-275.50%-372.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-561.53%-136.06%-201.82%-226.15%-220.51%-34.34%
FCF Yield
-108.15%-110.74%-105.86%-300.46%-193.74%-21.24%
Buyback Yield / Dilution
-791.51%-244.55%-240.54%-42.25%-34.69%-49.15%
SEC Filings: 10-K · 10-Q